April 25, 2024
Growing demand for anesthesia services at ASCs is being met with a dwindling supply of anesthesia providers....
This website uses cookies. to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking “Accept & Close”, you consent to our use of cookies. Read our Privacy Policy to learn more.
By: Daniel Cook
Published: 10/28/2008
The Methodist Ambulatory Surgery and Medical Center in San Antonio is the nation's unofficial capital for minimally invasive GYN, at least according to the facility's director of operations, Michelle Rhunke, RN. "If there's a new device out there, we've tried it," she says. Many of those devices treat patients who present with menorrhagia, the prolonged and heavy menstrual bleeding that can be caused by submucosal fibroids growing in the muscle along the inner lining of the uterus.
Hysterectomy remains the only proven way to completely treat the condition but the procedure's complexity and risk of complications relegate it to the ORs of acute care hospitals. Endometrial ablation and tissue morcellation are more conservative approaches for managing menorrhagia and are ideally suited for the ambulatory setting. The potential risks during these minimally invasive treatments of submucosal fibroids are rare and far outweighed by the procedure's efficacy and benefit to the patient, says Ms. Rhunke. "There are no large abdominal scars and no gas blown into the abdomen," she says. "Patients wake with minor cramping and are ready to go home in a matter of hours instead of days."
Ablation techniques
Use of a saline sonohysterogram - pelvic ultrasound with saline injected into the uterus - is the easiest method to detect a submucosal fibroid, says James H. Liu, MD, the Arthur H. Bill professor and chair of the Case Western Reserve University's Department of Reproductive Biology in Cleveland and physician at the Department of Obstetrics and Gynecology at Cleveland's MacDonald Women's Hospital. He says small submucosal fibroids - generally less than 2cm in diameter - can be treated with endometrial ablation. The ablation devices are inserted into the uterine cavity through the cervix.
Dr. Liu notes that patients suited for endometrial ablation experience excessive menstrual bleeding that limits daily activities and have tried unsuccessfully to curb the bleeding with medications or a dilatation and curettage procedure. In a study published in the July 2004 issue of the journal OBG Management, Dr. Liu reports excessive uterine bleeding is "bleeding exceeding 80ml per menses or a menstrual flow longer than seven days."
Here's a quick review of endometrial ablation treatment options.
When you compare the treatment options, you'll find each end in similar outcomes with similar risks. Dr. Liu reports short-term complications include uterine perforation, low-grade endometritis, cervical stenosis, hematometra and pelvic infection. These problems are rare, he says, while cramping pain following ablation is more common. "We suspect that this is due to cytokine release from the necrotic tissue," he explains, adding that intraoperative or post-op intravenous keterolac is often an effective analgesia against cramping discomfort.
Dr. Liu notes endometrial ablation procedures may need to be prepped with a dilatation and curettage procedure to remove excess endometrium or the administration of danazol or leuprolide to reduce estrogen stimulation of the endometrium in the month prior to the procedure. His report notes patients undergoing thermal fluid ablation should be treated with a gonadotropin-releasing hormone (GnRH) agonist or suction curettage. The typical pre-op treatment for each technique - except the radiofrequency energy procedure, which requires no pre-op preparation - consists of hormonal treatment with GnRH agonists over two menstrual cycles and suction dilatation and curettage, says Dr. Liu.
Tissue morcellation
If the submucosal fibroid is greater than 3cm, it is difficult to remove through the cervix unless the surgeon is quite skilled, says Dr. Liu. "In these cases, tissue morecellators are not used through the cervix because of insufficient visualization," he explains. "They are instead used when fibroids are removed via laparoscopy."
Fibroids are filled with very vascular tissue. When that vascular tissue is shaved during traditional hysteroscopy, the uterine cavity fills with blood particles that limit the surgeon's field of vision, increasing the potential for perforation of the uterine wall. The surgeon must remove the hysteroscope, suction the blood particles and replace the scope. That repeated maneuver increases the chance of puncturing the uterine wall.
The latest tissue morcellator devices pass through the hysteroscope. Surgeons visualize the uterus, locate a fibroid and place the morcellator against the lesion. Once activated, the morcellator twists into the fibroid, chews it up and simultaneously aspirates the debris. The surgical field remains clear and the scope remains in the uterine cavity for the duration of the case.
Those two factors make the procedure safer and quicker than traditional hysteroscopy. In fact, a study appearing in the January/February 2005 issue of the Journal of Minimally Invasive Gynecology reports the morcellation method reduces the average op time from just over 42 minutes to about 16 minutes.
Dr. Liu says the regenerative properties of endometrial tissue means anything short of a hysterectomy cannot be fully guaranteed to cure menorrhagia. Still, patients suffering from excessive menstrual bleeding are often in dire need of treatment. Without it they'd face a hysterectomy and an extended hospital stay, says Ms. Rhunke. These approaches to removing a potential cause of menorrhagia are not new to the outpatient arena but they are becoming more accepted as surgeons educate themselves - and patients - about their efficacy.
Growing demand for anesthesia services at ASCs is being met with a dwindling supply of anesthesia providers....
Improvements in both workflow and staff attitudes are part of a leader’s responsibilities, but your interventions in these areas don’t need to be major to make...
The ASC market continues its rapid growth. In 2023, roughly 116 new ASCs opened in the U.S., many of which were orthopedic-specific in nature....